17449-96-6|Clofezone|2-(4-chlorophenoxy)-N-(2-(diethylamino)ethyl)acetamide compound with 4-butyl-1,2-diphenylpyrazolidine-3,5-dione (11)|-范德生物科技公司

Clofezone

NMR下载 COA and HPLC MSDS下载
names：
2-(4-chlorophenoxy)-N-(2-(diethylamino)ethyl)acetamide compound with 4-butyl-1,2-diphenylpyrazolidine-3,5-dione (11)
CAS号：
17449-96-6
MDL Number：
MF(分子式)： C33H41ClN4O4 MW(分子量)： 593.17
EINECS: Reaxys Number:
Pubchem ID: Brand:BIOFOUNT

货品编码	规格	纯度	价格 (¥)	现价(¥)	特价(¥)	库存描述	数量	总计 (¥)

大包装询价提供各种包装，敬请垂询
收藏商品商品点评加入购物车立即购买

快速询价

收起

你想询价的产品

*产品名称：

CAS号：

产品编号：

需求描述：

请准确填写您的联系方式，以便为您提供最好的服务。

*公司名称：

*电子邮箱：

联系人：

*电话：

*验证码：

询价

中文别名	Clofezone
英文别名	Clofezone; Perclusone; Clofezonum
CAS号	17449-96-6
Inchi	InChI=1S/C19H20N2O2.C14H21ClN2O2/c1-2-3-14-17-18(22)20(15-10-6-4-7-11-15)21(19(17)23)16-12-8-5-9-13-16;1-3-17(4-2)10-9-16-14(18)11-19-13-7-5-12(15)6-8-13/h4-13,17H,2-3,14H2,1H3;5-8H,3-4,9-11H2,1-2H3,(H,16,18)
InchiKey	ICBCZMIEENEERJ-UHFFFAOYSA-N
分子式 Formula	C33H41ClN4O4
分子量 Molecular Weight	593.17
溶解度Solubility
性状	Solid powder
储藏条件 Storage conditions	Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).

产品说明	Clofezone(CAS:17449-96-6):仅限应用于工业或者科学研究过程中非医疗目的，不应用于人类或动物的临床诊断以及治过程疗，该产品非药用，非食用。
Introduction	Clofezone, also known as Perclusone, is an analgesic and antipyretic with anti-inflammatory properties used in treatment of rheumatism.
Application1
Application2
Application3

警示图
危险性	Warning
危险性警示
安全声明
安全防护
备注

[1]Brackertz D. Comparison of clofezone and diclofenac in the treatment of out-patients suffering from activated (painful) osteoarthrosis. Z Rheumatol. 1978 Sep-Oct;37(9-10):342-9. PubMed PMID: 153679.

[2]Reinicke C, Helbing M, Klingenfeld U, Lasaroff I, Wessel G. [Comparative studies on the bioavailability of various drug forms of phenylbutazone and clofezone (Perclusone)]. Pharmazie. 1984 Dec;39(12):824-7. German. PubMed PMID: 6241720.

[3] Celik CM. [Experiences in the management of rheumatoid diseases using different clofezone doses]. Z Rheumatol. 1976 May-Jun;35(5-6):240-7. German. PubMed PMID: 133565.

[4] Tamura T. [Clofezone and oxyphenbutazone excluded from dental use]. Nihon Shika Ishikai Zasshi. 1984;37(4):391-5. Japanese. PubMed PMID: 6241218.

[5] Keitel W, Weber G, Hoffmann H. [Results of comparative clinical examinations of antirheumatics: clofezone, indomethacin, phenylbutazone]. Schweiz Rundsch Med Prax. 1971 Jan 5;60(1):18-21. German. PubMed PMID: 5313620.

6: David-Chaussé J, David-Chaussé F, Lagoarde J, Picot C. [Therapeutic study of an anti-inflammatory agent, Clofezone]. J Med Bord. 1967 Oct;144(10):1529-35. French. PubMed PMID: 5304355.7: Stroescu I, Stoicescu M, Dragomir M, Burtea A, Pintea G, Stoia I. [Value of clofezone in the treatment of rheumatic diseases]. Schweiz Rundsch Med Prax. 1971 Feb 16;60(7):217-20. French. PubMed PMID: 5555631.8: Machtey I. [Short term clofezone therapy in rheumatic diseases]. Harefuah. 1971 Jun 5;80(12):654-6. Hebrew. PubMed PMID: 5156431.9: Kaiser H. [Clofezone, a new potent antirheumatic drug]. Munch Med Wochenschr. 1973 Dec 7;115(49):2247-8. German. PubMed PMID: 4205416.10: Ogawa K, Oguchi J, Okada S. [Use of clofezone (pans) in oral surgery]. Shikai Tenbo. 1978;51(2):385-9. Japanese. PubMed PMID: 161230.1

对不起，暂无产品评价！

MSDS

SDS 1.0 中文

展开

SDS 1.0 英文

展开